ParaTechs Scientific Advisory Board
Dr. Mike Adang, Chief Scientific Officer, Insectigen
Professor, University of Georgia
Michael Adang received his BS in microbiology from Indiana University in 1974 and his MSc and Phd in bacteriology from Washington State University in 1978 and 1981. He is a professor of entomology, biochemistry and molecular biology at the University of Georgia with ninety-five journal articles and book chapters and fifteen U.S. patents to his credit. As a senior research scientist at Agrigenetics Corp. in Madison, Wisconsin 1982-1988. Dr. Adang developed transgenic plants expressing proteins from Bacillus thuringiensis (Bt). These technologies have been used worldwide with significant impact on pest control in agriculture. Since 1988, his research has focused on receptors that determine Bt toxicity to insects. His laboratory was the first to discover that aminopeptidase and alkaline phosphatase function as Bt toxin receptors, with basic implications for Bt-plant development and usage. Adang has consulted for the government, Mycogen Corporation and DOW Agrosciences. Adang is on the scientific advisory board of ParaTechs. His global activities in the intellectual property area include patent preparation and prosecution activities with approximately twelve law firms over a 25-year period. In 2003, he co-founded InsectiGen, a start-up company focused on development of his invention, BtBooster, for insect control. Dr. Adang is the Chief Scientific Officer of InsectiGen.
Dr. Bryony Bonning, Professor, Iowa State University
Bryony Bonning, Professor and Director of the Virus-Insect Interactions Initiative at Iowa State University, USA received her PhD from the London School of Hygiene and Tropical Medicine, University of London, UK. She went on to postdoctoral appointments at the NERC Institute of Virology in Oxford, UK, and at the University of California, Davis, USA. Bonning currently oversees fundamental and applied research on insect physiology and insect pathology with the goal of developing novel, environmentally benign alternatives to chemical insecticides for insect pest management. Her research has included the study of insect hormones and enzymes and insecticidal toxins derived from Bacillus thuringiensis, insect small RNA, the genetic optimization of insect viruses for pest management, insect virus discovery and the use of viral proteins for development of insect resistant transgenic plants.Web site: http://www.ent.iastate.edu/dept/faculty/bonningb/
Dr. Linda Guarino, Professor Emeritus, Texas A&M University
Dr. Linda Guarino, Ph.D. is Professor Emerita at Texas A&M University. She received her bachelor’s and doctorate degrees from the University of Colorado. At Texas A&M University, she developed a research program centering on the regulation of gene expression in baculovirus-infected cells. Notable contributions to the field were: identification of essential early transcription factors; purification and identification of the baculovirus RNA polymerase; mechanistic studies of RNA capping and polyadenylation; and development of stable and transient expression systems based on early promoters.
Dr. Glenn King, Professor, University of Queensland, Australia
Glenn King is a Professorial Research Fellow in the Institute of Molecular Bioscience at the University of Queensland. Glenn graduated PhD from the University of Sydney before undertaking postdoctoral studies in the field of NMR structural biology at the University of Oxford. He was a faculty member in the Department of Biochemistry at the University of Sydney from 1989–1998 before joining the University of Connecticut as Professor of Biochemistry & Microbiology in 1999. He returned to Australia in 2007 to take up his current position. One of Glenn’s major interests over the past 15 years has been the structure, function, evolution, and potential applications of ion channel modulators from spider venoms. In 2006, Glenn founded an agricultural biotechnology company (Vestaron Corporation: www.vestaron.com) that is developing environmentally-friendly insecticides based on molecules discovered in his lab. Another major focus of Glenn’s research is using animal venoms to discover new leads for the treatment of chronic pain. Glenn’s lab has also developed a fully automated NMR pipeline for determining the high-resolution structure of peptide-drug leads. Glenn serves on the Scientific Advisory Boards of several companies and he is a Fellow of the American Academy of Microbiology.
Dr. Carlisle Landel
Dr. Carlisle Landel is currently the Senior Director, Custom Animal Model Division at Applied Stemcell Inc. in Milpitas California. Dr. Landel’s previous positions include Director of the Custom Animal Model Division at Transposagen Biopharmaceuticals Inc. in Lexington Kentucky, Director of the Transgenic and Gene Targeting Facility at Thomas Jefferson University in Philadelphia, and Co-Director of the Cryopreservation Program at the Jackson Laboratories. He has also held faculty positions at the A.I. DuPont Hospital for Children and the University of California at San Diego.
Dr. Brett Spear, University of Kentucky
Brett Spear is Professor in the Department of Microbiology, Immunology and Molecular Genetics and Director of the Transgenic Mouse Facility at the University of Kentucky. Dr. Spear received his PhD from the University of Pennsylvania and carried out postdoctoral work at the Fox Chase Cancer Center in Philadelphia and Princeton University. Dr. Spear’s research is focused on transcriptional regulation during liver development and disease, with an emphasis on mouse models to investigate the expression of hepatic enzymes involved in lipid homeostasis and cardiovascular disease. Dr. Spear is co-developer of the NSET device that is being developed further by ParaTechs. In addition to his research, Dr. Spear serves as Director of Graduate Studies for the University of Kentucky College of Medicine Integrated Biomedical Sciences PhD program. Web site: http://www.mc.uky.edu/microbiology/spear.asp